Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masami Nonaka

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2018
Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humansAkifumi Kogame, Ronald Lee, Liping Pan, et al.
Biopharmaceutics & Drug Disposition|July 25, 2008
Marked impact of P-glycoprotein on the absorption of TAK-427 in ratsToshiyuki Takeuchi, Masami Nonaka, Sumie Yoshitomi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 15, 2016
In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blockerHitomi Yamasaki, Naohiro Kawaguchi, Masami Nonaka, et al.
Scientific Reports|July 19, 2024
Impact of an unprecedented marine heatwave on extremely hot summer over Northern Japan in 2023Hirotaka Sato, Kazuto Takemura, Akira Ito, et al.
Frontiers in Public Health|September 12, 2022
Predicting malaria outbreaks from sea surface temperature variability up to 9 months ahead in Limpopo, South Africa, using machine learningPatrick Martineau, Swadhin K Behera, Masami Nonaka, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 27, 2016
Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogsAkifumi Kogame, Toshiyuki Takeuchi, Masami Nonaka, et al.
Journal of Medicinal Chemistry|April 12, 2012
Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agentNobuyuki Negoro, Shinobu Sasaki, Satoshi Mikami, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 21, 2018
Disposition and metabolism of the G protein-coupled receptor 40 agonist TAK-875 (fasiglifam) in rats, dogs, and humansAkifumi Kogame, Ronald Lee, Liping Pan, et al.
Biopharmaceutics & Drug Disposition|July 25, 2008
Marked impact of P-glycoprotein on the absorption of TAK-427 in ratsToshiyuki Takeuchi, Masami Nonaka, Sumie Yoshitomi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 15, 2016
In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blockerHitomi Yamasaki, Naohiro Kawaguchi, Masami Nonaka, et al.
Scientific Reports|July 19, 2024
Impact of an unprecedented marine heatwave on extremely hot summer over Northern Japan in 2023Hirotaka Sato, Kazuto Takemura, Akira Ito, et al.
Frontiers in Public Health|September 12, 2022
Predicting malaria outbreaks from sea surface temperature variability up to 9 months ahead in Limpopo, South Africa, using machine learningPatrick Martineau, Swadhin K Behera, Masami Nonaka, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 27, 2016
Disposition and metabolism of TAK-438 (vonoprazan fumarate), a novel potassium-competitive acid blocker, in rats and dogsAkifumi Kogame, Toshiyuki Takeuchi, Masami Nonaka, et al.
Journal of Medicinal Chemistry|April 12, 2012
Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agentNobuyuki Negoro, Shinobu Sasaki, Satoshi Mikami, et al.
Pageof 2